Modulatory effects on myocardial physiology induced by an anti- Trypanosoma cruzi monoclonal antibody involve recognition of major antigenic epitopes from β 1-adrenergic and M 2-muscarinic cholinergic receptors without requiring receptor cross-linking

Abstract

It has been proposed that anti-myocardial antibodies (Ab) against neurotransmitter (NT) receptors are involved in the immunopathology of chronic Chagas' heart disease. We demonstrated that an anti- Trypanosoma cruzi monoclonal Ab (mAb), CAK20.12, binds to murine cardiac β-adrenergic and muscarinic acetyl choline (mACh) receptors eliciting abnormal physiological responses on normal heart. No cross-linking requirement for mAb actions was demonstrated using Fab fragment derived from CAK20.12. mAb binding to synthetic peptides from the second extracellular loop of both β 1-adrenergic and mACh receptors, demonstrated by ELISA, identified the region of NT receptors involved. Cross-reactivity between these peptides and T. cruzi antigen was confirmed by binding inhibition assays. These results support the existence of cross-reactivity due to molecular mimicry between a parasite antigen and the major antigenic epitopes present on both β 1-adrenergic and M 2-ACh receptors. Its possible relationship with cardiac dysfunction during chronic stage of Chagas' disease is also discussed.